Skip to main content

Global Peripheral Vascular and Biliary Stents Market Size to Reach USD 7,405.9 Million in 2032 | Emergen Research

Increasing prevalence of cardiovascular and biliary diseases is a major factor driving Peripheral Vascular and Biliary Stents Market revenue growth

Vancouver, Dec. 19, 2023 (GLOBE NEWSWIRE) — The global peripheral vascular and biliary stents market size is expected to reach USD 7,405.9 Million in 2032 and register a revenue CAGR of 6.0% during the forecast period, according to the latest analysis by Emergen Research. Rising prevalence of cardiovascular and biliary diseases is one of the major factors driving the peripheral vascular and biliary stents market revenue growth. An estimated 8,000 individuals across the U.S. are diagnosed with bile duct cancer each year. A person with intrahepatic bile duct cancer is frequently identified at age 70. To avoid rising prevalence of biliary illnesses, biliary stents are becoming increasingly beneficial, which is driving market revenue growth. Peripheral vascular and biliary stents are in high demand due to the rise in minimally invasive treatments. An increasingly common method that allows for minimally invasive treatment of conditions that formerly required surgery is stenting. Vascular stents are typically implanted as part of peripheral artery angioplasty, a minimally invasive endovascular procedure to open up constrictive or blocked arteries or veins, frequently to treat arterial atherosclerosis.

The peripheral vascular and biliary stents face significant commercial limitations as a result of stringent regulatory clearance process. To get regulatory approval, these medical devices must meet strict safety and efficacy standards established by regulatory bodies. The lengthy and difficult approval process usually causes product launches to be postponed, which can restrain market revenue growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @   https://www.emergenresearch.com/request-sample/2150

Scope of Research

Report DetailsOutcome
Market size in 2022USD 4,124.6 Million
CAGR (2023-2032)6.0%
Revenue forecast to 2032USD 7405.9 Million
Base year for estimation2022
Historical data2019-2021
Forecast period2023-2032
Quantitative unitsRevenue in USD Million and CAGR in % from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends.
Segments coveredProduct type, material, end-use, region
Regional scopeNorth America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scopeU.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, Israel, Rest of MEA
Key companies profiledAbbott, BD, BIOTRONIK, Boston Medical Products Inc., Boston Scientific Corporation, Cook, Cordis, E. Benson Hood Laboratories, Inc., Medtronic, Merit Medical Systems
Customization scope10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2150

Major Companies and Competitive Landscape

The global peripheral vascular and biliary stents market is fragmented, with several large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective peripheral vascular and biliary stents services. Some major players included in the global peripheral vascular and biliary stents market report are:

  • Abbott
  • BD
  • BIOTRONIK
  • Boston Medical Products Inc.
  • Boston Scientific Corporation
  • Cook
  • Cordis
  • E. Benson Hood Laboratories, Inc.
  • Medtronic
  • Merit Medical Systems

Strategic Development

  • On 07 April 2023, the Stena Peripheral Flow Directing Stent was created by the Turkish medical company Invamed for the management of peripheral artery aneurysms. According to Invamed, these stents are adaptable to the walls of peripheral arteries since they are flexible, have a high bending capacity, and in addition, are fatigue resistant.
  • On 08 February 2023, Cardiovascular Systems, Inc. (CSI), a manufacturer of medical devices with a cutting-edge atherectomy system used to treat peripheral and coronary artery disease, and Abbott signed a formal agreement under which Abbott would acquire CSI. Abbott’s market-leading vascular device lineup will gain access to fresh, complementary innovations thanks to the purchase of CSI.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2150

Some Key Highlights from the Report

  • On 08 February 2023, a formal agreement between Abbott and Cardiovascular Systems, Inc. (CSI), a producer of medical equipment with a cutting-edge atherectomy system used to treat coronary and peripheral artery disease, was struck. Considering the acquisition of CSI, Abbott’s market-leading vascular device range will have access to new, complementary breakthroughs.
  • The peripheral vascular stents segment is expected to register a steady revenue CAGR during the forecast period. Peripheral vascular disease is becoming more common, which is driving revenue growth of this segment. Other disorders such as diabetes or coronary artery disease are typically present in patients with chronic peripheral vascular disease. Peripheral stents are frequently implanted alongside balloon angioplasty. Implanting peripheral stents helps keep a blocked or clogged artery open so that blood can flow through it.
  • The metal stents segment is expected to account for a significantly large revenue share during the forecast period. Stainless steel 316L, stainless steel 316LVM, nitinol, cobalt-chromium, titanium, tantalum alloys, and platinum-iridium alloy are among the biocompatible materials frequently used to make stents. Precision laser cutting technology is used to cut the complicated lattice-like patterns required for their extraordinary growth capabilities.
  • The market in North America is expected to account for largest revenue share during the forecast period. The region is recognized for its state-of-the-art medical infrastructure and technological advancements, which allowed the introduction of revolutionary stent technology. Furthermore, considerable Research and Development (R&D) activities, collaborations between business and academic institutions, and presence of key market competitors in North America are driving revenue growth of the peripheral vascular and biliary stents market.

Segments Covered in Report

For the purpose of this report, Emergen Research has segmented the global peripheral vascular and biliary stents market on the basis of product type, material, end-use, and region:

  • Product Type Outlook (Revenue, USD Million; 2019–2032)                                            
    • Peripheral Vascular Stents
      1. Self-Expanding Stents
      2. Balloon-Expandable Stents
      3. Drug-Eluting Stents
      4. Bare Metal Stents
    • Biliary Stents
      1. Plastic Stents
      2. Metal Stents
      3. Drug-Eluting Stents
  • Material Outlook (Revenue, USD Million; 2019–2032)                                           
    • Metal Stents
      1. Stainless Steel
      2. Nitinol
      3. Cobalt-Chromium Alloy
    • Polymer Stents
      1. Biodegradable Polymer
      2. Non-Biodegradable Polymer
  • End-Use Outlook (Revenue, USD Million; 2019–2032)                                            
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • Regional Outlook (Revenue, USD Million, 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. Spain
      5. BENELUX
      6. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Israel
      4. Rest of MEA

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/peripheral-vascular-and-biliary-stents-market  

Curated Reports You Shouldn’t Miss: Dive In Now!

Adherence Packaging Market By Type (Unit-dose Packaging Systems and Multi-dose Packaging Systems), By Material (Plastic, Paper & Paperboard, Aluminum), By End-use, and By Region Forecast to 2032

Clinical Laboratory Services Market, By Specialty (Clinical Chemistry Testing, Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, and Genetic Testing), By Provider, By Application, and By Region Forecast to 2032

Nerve Monitoring System Market, By Component (Software and Hardware), By Technology [Electromyography (EMG), Evoked Potential (EP), and Others], By Application (Neurosurgery, Spine Surgery, and Others), By End-Use, and By Region Forecast to 2032

Thermosphere Ablation Technology Market, By Technology (Thermal, Field, and Wavelength Control), By Application (Cardiology, Oncology, Gynaecology, Urology, Dermatology, and Others), By Region Forecast to 2032

Reflux Testing Products Market, By Product Type (pH Monitoring Systems, Impedance Testing Systems, and Others), By Disease Indication (Barrett’s esophagus, Reflux esophagitis, and Others), By End-Use, and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Explore Our Japanese Version:  Peripheral Vascular and Biliary Stents Market

Read our Press Release @ https://www.emergenresearch.com/press-release/global-peripheral-vascular-and-biliary-stents-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.